| Sintilimab for relapsed/refractory classical Hodgkin's lymphoma: Extended follow-up on the multicenter, single-arm phase II ORIENT-1 study. | |
| Su, Hang; Song, Yongping; Jiang, Wenqi; Sun, Xiuhua; Qian, Wenbin; Zhang, Wei; Gao, Yuhuan; Jin, Zhengming; Zhou, Jianfeng; Jin, Chu 更多 | |
| 2019 | |
| 会议名称 | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) |
| 会议日期 | MAY 31-JUN 04, 2019 |
| 卷号 | 37 |
| 期号 | 15 |
| 收录类别 | CPCI-S ; SCIE |
| 会议录 | JOURNAL OF CLINICAL ONCOLOGY
 |
| URL标识 | 查看原文 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6024601 |
| 专题 | 山东大学 |
| 作者单位 | 1.[Su, H 2.Song, YP 3.Jiang, WQ 4.Sun, XH 5.Qian, WB 6.Zhang, W 7.Gao, YH 8.Jin, ZM 9.Zhou, JF 10.Jin, C |
| 推荐引用方式 GB/T 7714 | Su, Hang,Song, Yongping,Jiang, Wenqi,et al. Sintilimab for relapsed/refractory classical Hodgkin's lymphoma: Extended follow-up on the multicenter, single-arm phase II ORIENT-1 study.[C]. 见:Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). MAY 31-JUN 04, 2019. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论